Second Quarter: Group Remains on Course in a Challenging Environment

The company registered the effects of the Covid-19 pandemic in all business sectors in the second quarter. Group sales increased by 3.7% to € 4.1 billion. EBITDA pre fell by -5.7% to € 1.1 billion.


Overview and outlook

Overview of Q2 2020

  • Sales rise by 3.7% to € 4.1 billion, EBITDA pre declines by -5.7% to € 1.1 billion
  • Healthcare and Performance Materials more strongly affected by the Covid-19 pandemic than Life Science
  • Process Solutions drives growth of Life Science

Outlook for fiscal 2020

  • Assumptions regarding the further course of the pandemic largely unchanged
  • Group sales between € 16.9 billion and € 17.7 billion expected; lower end of range raised for expected EBITDA pre; forecast is now € 4.45 billion to € 4.85 billion 
852 852 Pull Quote Oschmann Stefan 2018 Small 852 852 Pull Quote Oschmann Stefan 2018 Small

Despite considerable pandemic-related obstacles in some businesses, overall we did well in the second quarter. In recent months, we again proved the strengths of our diversified business model with three strong, innovation-driven business sectors.

Stefan Oschmann

Chairman of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

Conference calls for media and analysts

Annual Reports Archive

Find previous Annual Reports, Corporate Governance Reports & Statements in our archive.
Read more

Related News

View All News
  1. Press Releases

    Second Quarter: Group Remains on Course in a Challenging Environment

    Merck KGaA, Darmstadt, Germany, registered the effects of the Covid-19 pandemic in all business sectors in the second quarter. Healthcare and Performance Materials were affected most strongly.

    2020/08/06

Andreas Cezanne

Financial Communications

Constantin Fest

Head of Investor Relations

+49 6151 72-5271

+49 6151 72 91-5271

Upcoming Event

View All Events

Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.

Check Share Price

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Internet Explorer is not supported

You are using an outdated browser. If you would like to use our website, please use Chrome, Firefox, Safari or other browser

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement